29.09.2011 • NewsLonzaArch Chemicals

Lonza Obtains French Antitrust Clearance For Arch Chemicals Offer

Lonza Group, a supplier to the life science industries, said it has obtained antitrust clearance from the Autorité de la Concurrence in France for its tender offer for 100% of the outstanding shares of common stock of Arch Chemicals.

The tender offer is at a price of $47.20 per share in cash and remains subject to antitrust clearance in the U.S. The tender offer had previously been extended to September 30. It may be further extended if its conditions remain unsatisfied.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read